The in vitro effect of procainamide on plasma cholinesterase (PCHE) ors.o, 10.0, 20.0 and 40.O lzg.ml -l, was reduced to O.73 +-0.04.0.61 • 0.03, 0.45 • 0.02, and 0.36 • 0.01 units'ml -t, respectively The interaction between procainamide, a potent antiarrhythmic drug, and both depolarizing and nondepolarizing muscle relaxants has been documented in the sciatic nerve-tibialis anterior muscle preparation of the anaesthetized cat. ~ Procainamide is known to inhibit the release of acetylcholine at the neuromuscular junction and thus prolongs the duration of action of nondepoladzing muscle relaxants. 2 However, the mechanism for the interaction between procainamide and succinylcholine, a depolarizing muscle relaxant has not been elucidated. Intravenous infusion of procainamide hydrochloride in a dose range of 2 to 20 mg.kg -t had shown to have no neuromuscular blocking effect in the absence of muscle relaxants. ~ Proealne, an ester type of local anaesthetic, is also known to potentiate the action of suceinylcho[ine both in humans and in animals.3'4 Since procaine and succinylcholine are hydrolyzed by the same plasma cholinesterase enzyme, this potentiation of succinylcholine action was thought to be due to the substrate competition. 4 To our knowledge, the effect of procainamide on plasma cholinesterase activity has not been reported. Therefore, we studied the effect of proeainamide on pseudocholinesterdse in the plasma of ten healthy ASA physical status I patients.
The interaction between procainamide, a potent antiarrhythmic drug, and both depolarizing and nondepolarizing muscle relaxants has been documented in the sciatic nerve-tibialis anterior muscle preparation of the anaesthetized cat. ~ Procainamide is known to inhibit the release of acetylcholine at the neuromuscular junction and thus prolongs the duration of action of nondepoladzing muscle relaxants. 2 However, the mechanism for the interaction between procainamide and succinylcholine, a depolarizing muscle relaxant has not been elucidated. Intravenous infusion of procainamide hydrochloride in a dose range of 2 to 20 mg.kg -t had shown to have no neuromuscular blocking effect in the absence of muscle relaxants. ~ Proealne, an ester type of local anaesthetic, is also known to potentiate the action of suceinylcho[ine both in humans and in animals.3'4 Since procaine and succinylcholine are hydrolyzed by the same plasma cholinesterase enzyme, this potentiation of succinylcholine action was thought to be due to the substrate competition. 4 To our knowledge, the effect of procainamide on plasma cholinesterase activity has not been reported. Therefore, we studied the effect of proeainamide on pseudocholinesterdse in the plasma of ten healthy ASA physical status I patients.
Methods
With the prior approval of our Institutional Review Board for the Protection of Human Subjects, informed consent was obtained from ten healthy ASA physical status I patients (both sexes, aged 18 28), Ten ml ofwnous blood was collected into a heparinized syringe from each patient. Plasma was immediately separated for the determination of cholinesterase activity and dibucaine numbers (DN). A kinetic method described by Zapf el al. utilizing naphthyl acetate substrate was used in the determination of plasma cholinesterase activity and dibucaine numbers. 5 All the values reported were the average means of duplicate determinations of plasma cholinesterase activity.
The reaction mixture contained l-napbthyl acetate as substrate in phosphate buffer with a pH of 7.50. The total volume of the reaction mixture was 3 ml. Procainamide was added in vitro to the reaction mixture to give a final concentration of 5.0, 10.0, 20.0 and 40.0 i~g'ml L After determining a baseline absorbance at 321 nm in a Beckman Model 24 recording spectrophotometer, the reaction was started with the addition of 100 p,I of plasma sample. The absorbance change was recorded and cholinesterase activity was expressed as units per ml of plasma. One unit corresponds to the liberation of 1 mieromole of 1-napthol per minute under the conditions of assay.
Linear regression analyses and correlation coefficients were calculated between log procainamide concentrations and PCHE activities. Correlation coefficients (r) with corresponding p < 0.01 were considered significant. In addition to regression analyses, analysis of variance and Dunnett's test were used to compare the drug effects against the control. CAN I ANAESTH 1987 / 34:6 / pp579-81 
Results
Results are shown in Table I . The mean plasma cholinesterase activity of the control plasma samples was 0.90 units' ml-i. When procainamide was added to the reaction mixture to get a concentration of 5.0, 10.0, 20.0 and 40.0 Ixg'ml -~, the mean plasma cholinesterase activity was reduced to 0.73, 0.61, 0.45 and 0.36 units.m1 -t, respectively. Dibueaine numbers of all the plasma samples were in the normal range of 78 to 86. There was a significant correlation between log concentrations of procainamide versus PCHE activity (r = 0.99, p < 0.001) ( Table II) . The figure shows a plot of per cent inhibition of PCHE activity against log plasma proeainamide concentrations. The concentration of proeainamide required to inhibit 50 per cent of PCHE activity (lso) was found to be 20 t.tg.ml -t .
Discussion
Procainamide is an effective pharmacological agent used in the treatment of premature ventricular contractions and recurrent ventricular tachyeardia. 6 Procainamide is also useful in the treatment of ventricular dysrhythmias occur- ring in patients with malignant hyperpyrexia, v The therapeutic concentration of procainamide is considered as 4 to 12 ~g.mi -1 .s Plasma cholinesterase is a mueoprotein produced in the liver which is responsible for the metabolism of suecinylcholine, a depolarizing muscle relaxant and all the ester type of local anesthetics. Plasma cholinesterase has no documented physiological importance.
Several drugs are known to inhibit PCHE activity. 9't~ PCHE is also depressed in pregnant patients and in patients with significant hepatic dysfunction.ll'n Investigators have shown that there is a correlation between PCHE activity and the duration of paralysis produced by a single dose administration of succinylcholine. =3 However, the correlatory effect between PCHE activity and the recovery of muscLe twitch from the administration of multiple doses of succinytcholine has not been studied. The depressant effect of procainamide on PCHE activity may not be clinically significant in healthy patients with normal levels of PCHE activity. However, in patients with moderate decrease in PCHE activity as seen in pregnant patients and in patients with significant hepatic dysfunction, a further decrease in PCHE activity up to 30 per cent caused by procainamide could become clinically significant. Systemic toxicity caused by ester type local anaesthetics has been documented in patients with significant decrease in PCHE activity. ~4
In conclusion; we demonstrated that procainamide when tested in vitro has a statistically significant inhibitory effect on plasma chotinesterase activity (p < 0.01). Our data also showed that the concentration of procainamide required to inhibit 50 per cent of the plasma eholines-terase activity is 20 Ixg'ml t. We recommend that neuromuscular paralysis should be monitored with a peripheral nerve stimulator in patients receiving procainamide and muscle relaxants.
